Vivo Capital IX, LLC 13D and 13G filings for Sierra Oncology, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2022-07-05 5:06 pm Sale |
2022-07-01 | 13G | Sierra Oncology, Inc. SRRA |
Vivo Capital IX, LLC | 0 0.000% |
-2,735,852![]() (Position Closed) |
Filing |
2022-02-11 5:22 pm Purchase |
2022-01-31 | 13G | Sierra Oncology, Inc. SRRA |
Vivo Capital IX, LLC | 2,735,852 14.700% |
799,999![]() (+41.33%) |
Filing |
2021-11-05 5:00 pm Purchase |
2021-11-05 | 13G | Sierra Oncology, Inc. SRRA |
Vivo Capital IX, LLC | 1,935,853 14.800% |
480,277![]() (+33.00%) |
Filing |